A Mid-Sized Diagnostics Company Decides it Can't do Everything
The rapid consolidation in diagnostics doesn't leave room for mid-sized players like Chiron Corp., which has been looking for a strategic partner for its diagnostics subsidiary for some time. Chiron Diagnostics needs to expand the breadth of its product line, according to an executive at the company.
You may also be interested in...
If J&J’s gamble on a single dose pays off, it could rapidly advance the fight against SARS-CoV2 – but a second study will provide a safety net.
Agency has been prepping Woodcock for the temporary task but what will happen to her role on Operation Warp Speed remains unclear. The move should give Biden team cushion to confirm a permanent leader of whom a top contender is former senior FDA staffer Joshua Sharfstein, a proponent of drug reforms that may irk manufacturers.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.